Story perspectives

14 States Ban Tianeptine Amid Health Risks and Misleading Marketing

3/27/2026

Summary

Story summary

Fourteen states, including Connecticut, have classified tianeptine as a Schedule I controlled substance.
The FDA warns that tianeptine can be more potent than morphine and poses severe health risks, including respiratory depression and death.
Experts say tianeptine is often marketed misleadingly as a remedy for pain and anxiety.
Experts, including Dr. Robert Schwaner, emphasize the need for national regulation to address tolerance and dependence similar to opioids.

1 of 1

Story summary

Fourteen states, including Connecticut, have classified tianeptine as a Schedule I controlled substance.
The FDA warns that tianeptine can be more potent than morphine and poses severe health risks, including respiratory depression and death.
Experts say tianeptine is often marketed misleadingly as a remedy for pain and anxiety.
Experts, including Dr. Robert Schwaner, emphasize the need for national regulation to address tolerance and dependence similar to opioids.